BioWorld MedTech

March 2, 2016

View Archived Issues

Nexstim facing uncertain future after stroke rehabilitation device trial fails

Nexstim Plc faces an uncertain future with its Navigated Brain Therapy (NBT) for stroke rehabilitation after a phase III study of the device failed to meet its primary endpoint. Read More

In releasing list of outstanding devices, China is promoting its med-tech sector

Read More

FDA posts September 2015 warning letter to Rewalk for 522 study

Read More

Savara so good: Aerovanc inhaled vancomycin nears pivotal with $20M series C

Read More

FDA decisions on Neuro-Spinal Scaffold propel Invivo's INSPIRE study, stock forward

Read More

Financings

Read More

Appointments & advancements

Read More

Daily M&A

Read More

Other news to note

Read More

Product briefs

Read More

Oncology Extra

Read More